121 related articles for article (PubMed ID: 11919423)
1. Surrogate markers of disease in mastocytosis.
Akin C; Metcalfe DD
Int Arch Allergy Immunol; 2002 Feb; 127(2):133-6. PubMed ID: 11919423
[TBL] [Abstract][Full Text] [Related]
2. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
[TBL] [Abstract][Full Text] [Related]
3. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders.
Schwartz LB
Leuk Res; 2001 Jul; 25(7):553-62. PubMed ID: 11377680
[No Abstract] [Full Text] [Related]
5. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
Granerus G; Lönnqvist B; Roupe G
Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
[TBL] [Abstract][Full Text] [Related]
6. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
[TBL] [Abstract][Full Text] [Related]
7. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover.
Granerus G; Lönnqvist B; Nystrand J; Roupe G
Br J Dermatol; 1998 Nov; 139(5):858-61. PubMed ID: 9892955
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
9. Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.
Horny HP; Lange K; Sotlar K; Valent P
J Clin Pathol; 2003 Aug; 56(8):575-8. PubMed ID: 12890804
[TBL] [Abstract][Full Text] [Related]
10. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
11. Markers of mast cell degranulation.
Hogan AD; Schwartz LB
Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
[TBL] [Abstract][Full Text] [Related]
12. Microdialysis of histamine in the skin of patients with mastocytosis.
Krogstad AL; Roupe G
Exp Dermatol; 2001 Apr; 10(2):118-23. PubMed ID: 11260250
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry.
Li CY
Leuk Res; 2001 Jul; 25(7):537-41. PubMed ID: 11377678
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
15. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
van Toorenenbergen AW; Oranje AP
Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
[TBL] [Abstract][Full Text] [Related]
18. Serum tryptase and the laboratory diagnosis of systemic mastocytosis.
Schwartz LB; Irani AM
Hematol Oncol Clin North Am; 2000 Jun; 14(3):641-57. PubMed ID: 10909044
[TBL] [Abstract][Full Text] [Related]
19. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.
Akin C; Schwartz LB; Kitoh T; Obayashi H; Worobec AS; Scott LM; Metcalfe DD
Blood; 2000 Aug; 96(4):1267-73. PubMed ID: 10942367
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers.
D'ambrosio C; Akin C; Wu Y; Magnusson MK; Metcalfe DD
J Allergy Clin Immunol; 2003 Dec; 112(6):1162-70. PubMed ID: 14657877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
